基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the detailed record of transactions filed by Pittman Scott M., 董事. Officer active across 1 company, notably Nuo Therapeutics, Inc.. In total, 6 filings have been logged. History available since 29 April 2022. The latest transaction was filed on 30 July 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Scott M. Pittman is a Board Member at Nuo Therapeutics, Inc. He actively participates in strategic discussions at the board level, bringing his experience in management and innovation. His role is essential for the company's development.